India's Aurobindo Pharma Ltd. is looking to buy the European business of privately held Apotex Inc. in a deal that could be valued at $100 million, The Economic Times reported.

The Canadian drugmaker is planning to divest its European business as part of a wider consolidation effort, the Indian newspaper reported citing industry sources.

Both Aurobindo and Apotex are manufacturers of generic drugs.